How many stocks are there of Veradigm?
The current number of stocks of Veradigm is 138.7 M undefined.
Veradigm Stocks 2024
Veradigm Stocks
138.7 M
Ticker
MDRX
ISIN
US01988P1084
WKN
607917
In 2024, Veradigm had 138.7 M outstanding stocks, a 0% change from the 138.7 M stocks in the previous year.
The Veradigm Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2028e | 138.7 |
| 2027e | 138.7 |
| 2026e | 138.7 |
| 2025e | 138.7 |
| 2024e | 138.7 |
| 2023e | 138.7 |
| 2022e | 138.7 |
| 2021 | 138.7 |
| 2020 | 159.3 |
| 2019 | 166.3 |
| 2018 | 176 |
| 2017 | 180.8 |
| 2016 | 186.2 |
| 2015 | 185.1 |
| 2014 | 179.8 |
| 2013 | 177 |
| 2012 | 178.7 |
| 2011 | 191 |
| 2010 | 148.4 |
| 2009 | 127 |
| 2008 | 82.9 |
| 2007 | 64.7 |
| 2006 | 53.4 |
| 2005 | 43.1 |
| 2004 | 41.6 |
| 2003 | 38.6 |
| 2002 | 38.3 |
Veradigm shares outstanding US01988P1084 · 607917
The number of shares was Veradigm in 2023 — This indicates how many shares 138.7 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Veradigm earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Veradigm's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Veradigm’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Veradigm's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2002 | 38.3 M Aktien |
| 2003 | 38.6 M Aktien |
| 2004 | 41.6 M Aktien |
| 2005 | 43.1 M Aktien |
| 2006 | 53.4 M Aktien |
| 2007 | 64.7 M Aktien |
| 2008 | 82.9 M Aktien |
| 2009 | 127 M Aktien |
| 2010 | 148.4 M Aktien |
| 2011 | 191 M Aktien |
| 2012 | 178.7 M Aktien |
| 2013 | 177 M Aktien |
| 2014 | 179.8 M Aktien |
| 2015 | 185.1 M Aktien |
| 2016 | 186.2 M Aktien |
| 2017 | 180.8 M Aktien |
| 2018 | 176 M Aktien |
| 2019 | 166.3 M Aktien |
| 2020 | 159.3 M Aktien |
| 2021 | 138.7 M Aktien |
| 2022e | 138.7 M Aktien |
| 2023e | 138.7 M Aktien |
| 2024e | 138.7 M Aktien |
| 2025e | 138.7 M Aktien |
| 2026e | 138.7 M Aktien |
| 2027e | 138.7 M Aktien |
| 2028e | 138.7 M Aktien |
Veradigm Aktienanalyse
What does Veradigm do?
Allscripts Healthcare Solutions Inc is one of the leading companies in the digital healthcare sector in the USA. The company was founded in 1982 and has since become one of the most important providers of IT solutions in healthcare. Allscripts supports healthcare providers in improving patient care and efficiency through the development and provision of innovative software and IT solutions. The business model of Allscripts is based on the development and sale of web-based software solutions for medical documentation and hospital management. These solutions are mainly distributed to hospitals and practices through subscriptions or licenses. Allscripts offers a variety of products that focus on various areas of medical care. One of the main divisions of the company is the electronic health records system (EHR). This system allows for the electronic recording, storage, and management of medical data and information. This enables healthcare providers to quickly and easily access patient information and document important diagnoses and treatments. Another important division of Allscripts is the Revenue Cycle Management (RCM), which optimizes billing and payment processes in hospitals and practices. In addition, Allscripts also offers solutions for telemedicine, including patient portal applications, remote patient monitoring systems, and mobile apps for patients and providers. Allscripts is based in Chicago and employs over 10,000 employees in various countries. The company also maintains partnerships with other companies in healthcare to facilitate and improve the complexity of digital transformation in the healthcare market. This includes companies like Microsoft, who work together with Allscripts on the development of artificial intelligence for healthcare applications. Allscripts' portfolio of offerings is very broad and provides customers with a variety of software solutions for different areas of medical care. The products are particularly characterized by their user-friendly interfaces, flexibility, and scalability. This allows customers to customize the solutions to their specific needs and consider future requirements. However, some products have been criticized for their expandability, poor design, and slow loading times. Recently, Allscripts has made a number of investments in research and development to address these issues and optimize the applications. In summary, Allscripts Healthcare Solutions Inc is considered one of the leading providers of software and IT solutions in healthcare in the USA. Thanks to a wide range of products and close collaboration with partners in healthcare, Allscripts is able to offer its customers innovative and scalable solutions that help them optimize their business processes and improve the quality of their medical care. Veradigm ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Veradigm's Shares Outstanding
Veradigm's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Veradigm’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Veradigm’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Veradigm’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Veradigm stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Veradigm are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Veradigm evolved in recent years?
The number of shares of Veradigm has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Veradigm as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Veradigm?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Veradigm pay?
Over the past 12 months, Veradigm paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Veradigm is expected to pay a dividend of 0 USD.
What is the dividend yield of Veradigm?
The current dividend yield of Veradigm is .
When does Veradigm pay dividends?
Veradigm pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Veradigm?
Veradigm paid dividends every year for the past 0 years.
What is the dividend of Veradigm?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Veradigm located?
Veradigm is assigned to the 'Health' sector.
Wann musste ich die Aktien von Veradigm kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Veradigm from 8/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/9/2024.
When did Veradigm pay the last dividend?
The last dividend was paid out on 8/9/2024.
What was the dividend of Veradigm in the year 2023?
In the year 2023, Veradigm distributed 0 USD as dividends.
In which currency does Veradigm pay out the dividend?
The dividends of Veradigm are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Veradigm
Our stock analysis for Veradigm Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Veradigm Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
